Efficacy of HA130 Hemoadsorption in Removing Advanced Glycation End Products in Maintenance Hemodialysis Patients
Artificial Organs · 2025
DOI: 10.1111/aor.14954 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Artificial Organs, 2025. Verfasst von Gonzalo Ramírez-Guerrero und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Dialysis Unit, Carlos Van Buren Hospital, Valparaíso, Chile. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Renal Dialysis, Kidney Failure, Chronic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Patients on maintenance hemodialysis (HD) face complications due to the accumulation of protein‐bound uremic toxins, such as advanced glycation end products (AGEs), which contribute to inflammation, oxidative stress, and cardiovascular disease. Conventional HD techniques inadequately remove AGEs. This study evaluates the efficacy of the HA130 hemoadsorption cartridge combined with high‐flux HD (HF‐HD) in enhancing AGE removal.
Methods
This prospective, single‐center study included 20 maintenance HD patients randomized into two groups: HF‐HD alone ( n = 10) and HF‐HD plus hemoadsorption ( n = 10). Blood samples were collected before and after a single session to measure carboxymethyllysine (CML), soluble RAGE (sRAGE), prolactin, and parathyroid hormone (PTH) levels. Reduction ratios (RR) were calculated, including corrected for hemoconcentration (RRc), to ensure accuracy. Statistical analyses included Mann–Whitney U and Chi‐square tests.
Results
The HF‐HD plus hemoadsorption group showed significantly enhanced removal of CML compared to HF‐HD alone, with RRc of 64.7% [52.6–74.9] versus 39.3% [33.8–49.4], respectively ( p = 0.045). Similarly, uncorrected reduction ratios demonstrated a trend favoring hemoadsorption, with values of 57.5% [45.1–70.7] versus 30.3% [19.1–44.5] ( p = 0.053). Importantly, sRAGE levels were preserved in both groups (RRc: 23.4% (15.1–30.4) vs. 21.8% (16.6–31.7), p = 0.791), highlighting the safety of hemoadsorption. Other biochemical parameters, including prolactin, PTH, albumin, and electrolytes, showed no significant differences between groups. All sessions were completed without adverse events.
Conclusion
Combining hemoadsorption with HF‐HD significantly enhances CML removal, as evidenced by corrected RR, without compromising protective sRAGE levels. This innovative approach offers a promising adjunctive therapy for reducing AGEs‐related complications in end‐stage renal disease patients. Further longitudinal studies are needed to confirm these findings and evaluate long‐term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nephrology and Dialysis Unit, Carlos Van Buren Hospital, Valparaíso, Chile.
- International Renal Research Institute of Vicenza, Vicenza, Italy.
- Laboratory of Molecular Pharmacology, Faculty of Health Sciences, University of Brasília, Brasília, Brazil.
- Division of Nephrology, University of São Paulo Medical School, São Paulo, Brazil.
- CPQuali Pesquisa Clínica, Clinical Research Center, São Paulo, Brazil.
- Departamento de Medicina Interna, Facultad de Medicina, Universidad de Concepción, Concepción, Chile.
ORCID-Profile: Gonzalo Ramírez-Guerrero, Thiago Reis
Zitieren
APA
Ramírez-Guerrero, G., Reis, T., Segovia-Hernández, B., Aranda, F., Verdugo, C., Pedreros-Rosales, C., Marcello, M., León, J., Rojas, A., Galli, F., & Ronco, C. (2025). Efficacy of HA130 Hemoadsorption in Removing Advanced Glycation End Products in Maintenance Hemodialysis Patients. Artificial Organs. https://doi.org/10.1111/aor.14954
Vancouver
Ramírez-Guerrero G, Reis T, Segovia-Hernández B, Aranda F, Verdugo C, Pedreros-Rosales C, et al. Efficacy of HA130 Hemoadsorption in Removing Advanced Glycation End Products in Maintenance Hemodialysis Patients. Artificial Organs. 2025. doi:10.1111/aor.14954
BibTeX
@article{RamrezGuerrero2025,
author = {Ramírez-Guerrero, Gonzalo and Reis, Thiago and Segovia-Hernández, Barbara and Aranda, Francisca and Verdugo, Constanza and Pedreros-Rosales, Cristian and Marcello, Matteo and León, Janina and Rojas, Armando and Galli, Francesco and Ronco, Claudio},
title = {Efficacy of HA130 Hemoadsorption in Removing Advanced Glycation End Products in Maintenance Hemodialysis Patients},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.14954}
}
EUVIMED